Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rabaud

Showing results (201-210 of 255) with videos related to

Pageof 26
Sort By:
Archives of Dermatological Research|January 1, 1987
Collagen studies in congenital cutis laxaA Taïeb, M Aumailley, D Courouge-Dorcier, et al.
AIDS (London, England)|August 24, 2010
Tolerability of HIV postexposure prophylaxis with tenofovir/emtricitabine and lopinavir/ritonavir tablet formulationWilliam Tosini, Philippe Muller, Thierry Prazuck, et al.
Scandinavian Journal of Infectious Diseases|December 1, 2001
Adverse reactions to cotrimoxazole in HIV-infected patients: predictive factors and subsequent HIV disease progressionC Rabaud, I Charreau, S Izard, et al.
Medecine Et Maladies Infectieuses|April 13, 2010
[Study of new HIV infection between 2000 and 2007 in the north and east of France]S Henard, L Letranchant, A Borel, et al.
AIDS Patient Care and Stds|January 26, 2010
Tolerability of two different combinations of antiretroviral drugs including tenofovir used in occupational and nonoccupational postexposure prophylaxis for HIVChristine Burty, Thierry Prazuck, Francois Truchetet, et al.
Medecine Et Maladies Infectieuses|October 6, 2012
Relevance of fluoroquinolone use in a French teaching hospitalL Rughoo, T Doco-Lecompte, S Henard, et al.
Microorganisms|August 7, 2021
Perceptions, Representations, and Experiences of Patients Presenting Nonspecific Symptoms in the Context of Suspected Lyme BorreliosisAlice Raffetin, Aude Barquin, Steve Nguala, et al.
Journal of Clinical Microbiology|September 10, 2010
Gluconobacter as well as Asaia species, newly emerging opportunistic human pathogens among acetic acid bacteriaCorentine Alauzet, Corinne Teyssier, Estelle Jumas-Bilak, et al.
Lancet (London, England)|September 16, 2016
Hepatitis C: the path towards effective universal therapyLionel Piroth, Christian Rabaud, David Rey, et al.
HIV Medicine|March 28, 2008
Causes of the first AIDS-defining illness and subsequent survival before and after the advent of combined antiretroviral therapyS Grabar, E Lanoy, C Allavena, et al.
Pageof 26

Showing results (201-210 of 255) with videos related to

Sort By:
Pageof 26
Archives of Dermatological Research|January 1, 1987
Collagen studies in congenital cutis laxaA Taïeb, M Aumailley, D Courouge-Dorcier, et al.
AIDS (London, England)|August 24, 2010
Tolerability of HIV postexposure prophylaxis with tenofovir/emtricitabine and lopinavir/ritonavir tablet formulationWilliam Tosini, Philippe Muller, Thierry Prazuck, et al.
Scandinavian Journal of Infectious Diseases|December 1, 2001
Adverse reactions to cotrimoxazole in HIV-infected patients: predictive factors and subsequent HIV disease progressionC Rabaud, I Charreau, S Izard, et al.
Medecine Et Maladies Infectieuses|April 13, 2010
[Study of new HIV infection between 2000 and 2007 in the north and east of France]S Henard, L Letranchant, A Borel, et al.
AIDS Patient Care and Stds|January 26, 2010
Tolerability of two different combinations of antiretroviral drugs including tenofovir used in occupational and nonoccupational postexposure prophylaxis for HIVChristine Burty, Thierry Prazuck, Francois Truchetet, et al.
Medecine Et Maladies Infectieuses|October 6, 2012
Relevance of fluoroquinolone use in a French teaching hospitalL Rughoo, T Doco-Lecompte, S Henard, et al.
Microorganisms|August 7, 2021
Perceptions, Representations, and Experiences of Patients Presenting Nonspecific Symptoms in the Context of Suspected Lyme BorreliosisAlice Raffetin, Aude Barquin, Steve Nguala, et al.
Journal of Clinical Microbiology|September 10, 2010
Gluconobacter as well as Asaia species, newly emerging opportunistic human pathogens among acetic acid bacteriaCorentine Alauzet, Corinne Teyssier, Estelle Jumas-Bilak, et al.
Lancet (London, England)|September 16, 2016
Hepatitis C: the path towards effective universal therapyLionel Piroth, Christian Rabaud, David Rey, et al.
HIV Medicine|March 28, 2008
Causes of the first AIDS-defining illness and subsequent survival before and after the advent of combined antiretroviral therapyS Grabar, E Lanoy, C Allavena, et al.
Pageof 26